Lindbrook Capital LLC Raises Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Lindbrook Capital LLC grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1,342.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 721 shares of the company’s stock after purchasing an additional 671 shares during the quarter. Lindbrook Capital LLC’s holdings in Acadia Healthcare were worth $29,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Inceptionr LLC purchased a new stake in shares of Acadia Healthcare during the 4th quarter worth $614,000. Raymond James Financial Inc. purchased a new stake in Acadia Healthcare in the fourth quarter valued at about $5,134,000. Aigen Investment Management LP purchased a new stake in Acadia Healthcare in the fourth quarter valued at about $701,000. M&T Bank Corp raised its stake in Acadia Healthcare by 9.5% in the fourth quarter. M&T Bank Corp now owns 15,352 shares of the company’s stock valued at $609,000 after buying an additional 1,327 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in Acadia Healthcare by 9.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,234,223 shares of the company’s stock valued at $48,937,000 after buying an additional 107,162 shares during the last quarter.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on ACHC shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Barclays lowered Acadia Healthcare from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $43.00 to $35.00 in a report on Friday, February 28th. Finally, TD Cowen dropped their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $56.31.

Acadia Healthcare Stock Up 2.2 %

Acadia Healthcare stock opened at $30.57 on Friday. The firm has a market cap of $2.84 billion, a price-to-earnings ratio of 10.02, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. Acadia Healthcare Company, Inc. has a 52 week low of $28.09 and a 52 week high of $84.44. The business’s 50-day moving average price is $41.32 and its 200 day moving average price is $50.24. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.